Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J. Campbell, Morgan H. James, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock T. Shireman, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 42
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
The potential role of the orexin reward system in future treatments for opioid drug abuse
Shahram Zarrabian, Esmail Riahi, Sara Karimi, et al.
Brain Research (2018) Vol. 1731, pp. 146028-146028
Closed Access | Times Cited: 39
Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure
Marlene A. Wilson, Israel Liberzon, Merry L. Lindsey, et al.
Stress (2019) Vol. 22, Iss. 5, pp. 530-547
Open Access | Times Cited: 36
Appetitive associative learning recruits a distinct network with cortical, striatal, and hypothalamic regions
Shelley A. Cole, Michael Hobin, Gorica D. Petrovich
Neuroscience (2014) Vol. 286, pp. 187-202
Open Access | Times Cited: 39
Narcolepsy and emotional experience: a review of the literature
C. Schiappa, Serena Scarpelli, Aurora D’Atri, et al.
Behavioral and Brain Functions (2018) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Neuroscience of opiates for addiction medicine
Yan Zhou, Francesco Leri
Progress in brain research (2015), pp. 237-251
Closed Access | Times Cited: 34
Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction
Amanda C. Sharko, Jim R. Fadel, Kris F. Kaigler, et al.
Physiology & Behavior (2016) Vol. 178, pp. 93-102
Open Access | Times Cited: 32
Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease
Miloš Stanojlović, Jean Pierre Pallais, Michael K. Lee, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 30
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Neuropharmacology of compulsive eating
Catherine F. Moore, Julia I. Panciera, Valentina Sabino, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2018) Vol. 373, Iss. 1742, pp. 20170024-20170024
Open Access | Times Cited: 31
Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits
Manoranjan S. D’Souza
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 29
Altered neural connectivity in adult female rats exposed to early life social stress
Benjamin C. Nephew, Wei Huang, Guillaume L. Poirier, et al.
Behavioural Brain Research (2016) Vol. 316, pp. 225-233
Open Access | Times Cited: 28
Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats
Alessandra Matzeu, Rémi Martin‐Fardon
Neuropharmacology (2019) Vol. 164, pp. 107906-107906
Open Access | Times Cited: 28
The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
Brain Research (2019) Vol. 1731, pp. 146222-146222
Open Access | Times Cited: 26
Dysregulation of the orexinergic system: A potential neuropeptide target in depression
Sharafuddin Khairuddin, Luca Aquili, Boon Chin Heng, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 118, pp. 384-396
Closed Access | Times Cited: 24
New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway
Hannah E. Bowrey, Morgan H. James, Gary Aston‐Jones
Depression and Anxiety (2017) Vol. 34, Iss. 7, pp. 588-595
Open Access | Times Cited: 26
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder
Kathryn M. Connor, Paulette Ceesay, Jill Hutzelmann, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 8, pp. 613-618
Open Access | Times Cited: 25
Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson’s Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity
Miloš Stanojlović, Jean Pierre Pallais Yllescas, Aarthi Vijayakumar, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8435-8450
Open Access | Times Cited: 25
Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses
Santosh Kumar Prajapati, Sairam Krishnamurthy
Behavioural Brain Research (2020) Vol. 399, pp. 113015-113015
Closed Access | Times Cited: 23
Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 22
Targeting the Orexin System for Prescription Opioid Use Disorder
Alessandra Matzeu, Rémi Martin‐Fardon
Brain Sciences (2020) Vol. 10, Iss. 4, pp. 226-226
Open Access | Times Cited: 22
Novel approaches for the treatment of psychostimulant and opioid abuse – focus on opioid receptor-based therapies
Christopher Bailey, Stephen M. Husbands
Expert Opinion on Drug Discovery (2014) Vol. 9, Iss. 11, pp. 1333-1344
Open Access | Times Cited: 22
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
David E. Moorman
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1663-1680
Open Access | Times Cited: 22

Scroll to top